waveCore LLC

Financings During the opening quarter of 2014, biopharma companies raised $9.8 billion (up 53% from Q4), with 18% of the deals having a value of $100 million or greater. ( See Exhibit 1. ) Follow-on p

IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Gene Technology Ltd. Cytocell Technologies Ltd. Genetics research and biomarker discovery firm Oxford Gene Technology Ltd. (OGT) bought fellow UK

Financings In the fourth quarter of 2013, start-up companies raised an aggregate of $1.18 billion, more than double Q3’s $559.4 million. That total is the highest we’ve seen in five years; 89% ($1.04

Financings In the fourth quarter of 2013, start-up companies raised an aggregate of $1.18 billion, more than double Q3’s $559.4 million. That total is the highest we’ve seen since START-UP began fea